drugset / Trial / NCT00247650

Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy

NCT00247650

Phase 2 Completed 190 enrolled Novartis
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is to measure the extent of tumor shrinkage when Letrozole and Zoledronic Acid are given before surgery to newly diagnosed post-menopausal women with early breast cancer

Timeline

Start
2005-09
Primary completion
2007-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Letrozole Other / unclassified
Subject Zoledronic acid Other / unclassified

Indications